News | January 09, 2025
GEON Performance Solutions acquires Foster Corporation
Acquisition expands high-value medical platform
Acquisition expands high-value medical platform
He also laid the foundation stone for a state-of-the-art 50-bedded Critical Care Block (CCB)
The cornerstone of the quality ecosystem is the implementation of the Quality Control Orders
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
The biosimilar Ustekinumab has been developed and manufactured by the company
ICMR will continue to track trends in HMPV circulation throughout the year
The order, part of an international framework agreement is to be executed between February to April, 2025
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
DOVBLERON marks the 13th addition to Innovent’s commercial portfolio
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
Subscribe To Our Newsletter & Stay Updated
